Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico

Journal of Urban Health

Volumn 83, Issue 6, 2006, Pages 1105-1113

  Reyes, Juan C ^a   Colón, Héctor M ^a   Robles, Rafael R ^a   Rios, Eddy ^b   Matos, Tomás D ^a   Negrón, Juan ^a   Marrero, Carmen Amalia ^a   Calderón, José M ^a   Shepard, Elizabeth ^a  

^a SCHOOL OF MEDICINE   (Puerto Rico)

^b Universidad Central del Caribe School of Medicine   (Puerto Rico)

Author keywords

Hepatitis C; Injection drug users; Puerto Rico; Shooting gallery; Tattooing

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG USE; EDUCATION PROGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PUERTO RICO; SELF REPORT; SEROPREVALENCE; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PUERTO RICO; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33845884822     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-006-9109-7     Document Type: Article

References (44)

1. Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect. 2002;129(3):577-585.
2. Abdala N, Carney J, Durante A, et al. Estimating the prevalence of syringe-borne and sexually transmitted diseases among injection drug users in St Petersburg, Russia. Int J STD AIDS. 2003;14(10):697-703.
3. Alter M. Hepatitis C virus infection in the United States. J Hepatol. 1999;31(Suppl 1):88-91.
4. Garten R, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004;33(1):182-188.
5. Trepo C, Pradat P. Hepatitis C virus infection in Western Europe. J Hepatol. 1999;31(Suppl 1):80-83.
6. Weissenbacher M, D R, Radulich G, et al. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina. Clin Infect Dis. 2003;15(37 Suppl 5):S348-352.
7. Alter M, Moyer L. The importance of preventing hepatitis C virus infection among injection drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(Suppl 1):S6-10.
8. Diaz T, Buehler J, Castro K, Ward J. AIDS trends among Hispanics in the United States. Am J Public Health. 1993;83(4):504-509.
9. Selik R, Castro K, Pappaioanou M. Racial/ethnic differences in the risk of AIDS in the United States. Am J Public Health. Dec 1988;78(12):1539-1545.
10. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2003;13(2).
11. Deren S, Robles R, Andia J, Colon H, Kang S, Perlis T. Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York. J Acquir Immune Defic Syndr Hum Retrovirol. 1 Feb 2001;26(2):164-169.
12. Deren S, Kang S, Colon H, Andia J, Robles R. HIV incidence among high-risk Puerto Rican drug users: a comparison of East Harlem, New York, and Bayamón, Puerto Rico. J Acquir Immune Defic Syndr. 15 Aug 2004;36(5):1067-1074.
13. Colon H, Robles R, Deren S, et al. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamón, Puerto Rico. J Acquir Immune Defic Syndr Hum Retrovirol. 2001;27(4):405-413.
14. Finlinson H, Colon H, Lopez M, Robles R, Cant J. Injecting shared drugs: an observational study of the process of drug acquisition, preparation, and injection by Puerto Rican drug users. J Psychoactive Drugs. 2005;37:37-49.
15. Montoya I, Bell D, Richard A, Carlson J, Trevino R. Estimated HIV risk among Hispanics in a national sample of drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;21(1):42-50.
16. Cagle H, Fisher D, Senter T, Thurmond R, AJ K. Classifying skin lesions of injection drug users: a method for corroborating disease risk. DHHS Pub. No. (SMA) 03-3771. Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration. 2002.
17. Robles R, Colón H, Freeman D. Copping areas as sampling and recruitment sites for out-of-treatment crack and injection drug users. Drugs and Society. 1993;7:91-105.
18. Fisher D, Needle R, Weatherby N, Brown B, Booth R, Williams M. Reliability of drug user self report. In: Abstract Book, IX International Conference on AIDS, June 6-11, 1993; Berlin, Germany, Abstract no. PO-C35-3355.
19. Needle R, Weatherby N, Chitwood D, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addictive Behaviors. 1995;9:242-250.
20. Robles R, Colón H, Sahai H, Matos T, Marrero C, Reyes J. Behavioral risk factors and human immunodeficiency virus (HIV) prevalence among intravenous drug users in Puerto Rico. Am J Epidemiol. 1992;135:531-540.
21. Habib S, Lovejoy F, Aspin C. Hepatitis C prevalence and risk behavior of injecting drug users in Sydney: a continuing concern. Southeast Asian J Trop Med Public Health. 2001;32(4):823-834.
22. Oliveira M, Bastos F, Telles P, et al. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Braz J Med Biol Res. 1999;32(9):1107-1114.
23. Quaglio G, Lugoboni F, Pajusco B, et al. Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy. J Viral Hepatitis. 2003;10(5):394-400.
24. Diaz T, Des Jarlais D, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health. 2001;91(1):23-30.
25. Garfein R, Vlahov D, Galai N, Doherty M, Nelson KE. Viral infections in short-term injection drug users: the prevalence of hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655-661.
26. Hahn J, Page-Shafer K, Lum P, Ochoa K, Moss AR. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology. 2001;34(1):180-187.
27. Thorpe L, Ouellet L, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155(7):645-653.
28. Reyes J, Robles R, Colón H, Freeman D, Sahai H, Matos TD. Risk factors for shooting gallery use among drug injectors in Puerto Rico. Puerto Rico Health Sci J. 1996;15:227-231.
29. Robles R, Marrero C, Reyes J, et al. Risk behaviors, HIV seropositivity and TB infection among IDUs who operate shooting galleries in Puerto Rico. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17:477-483.
30. Battjes R, Pickens R, Haverkos H, Sloboda Z. HIV risk factors among injecting drug users in five U.S. cities. AIDS. May 1994;8(5):681-687.
31. Hien N, Giang L, Binh P, Wolffers I. The social context of HIV risk behaviour by drug injectors in Ho Chi Minh City, Vietnam. AIDS Care. Aug 2000;12(4):483-495.
32. Strathdee S, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 28 May 2001;161(10):1281-1288.
33. Thorpe L, Ouellet L, Levy J, Williams I, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis. 2000; 182(6):1588-1594.
34. Villano S, Vlahov D, Nelson K, Lyles C, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol. 1997;35(12):3274-3277.
35. Champion J, Taylor A, Hutchinson S, et al. Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study. Am J Epidemiol. 2004;159(5):514-519.
36. Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M. Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol Infect. 1999;123(1):95-102.
37. Esteban J, Lopez-Talavera J,Genesca J, et al.High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med. 1991;115(6):443-449.
38. Meyer R, Gordon S. Epidemiology of hepatitis C virus infection in a suburban Detroit community. Am J Gastroenterol. 1991;86(9):1224-1226.
39. Samuel M, Doherty P, Bulterys M, Jenison SA. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B andC positivity among street-recruited injecting drug users in NewMexico, USA. Epidemiol Infect. Dec 2001;127(3):475-484.
40. Iwamura K, Pronai L, Nishioka K, Watanabe J. Incidence of hepatitis C in chronic liver diseases following tattooing. Orv Hetil. 1992;133(15):923-925.
41. Entz A, Ruffolo V, Chinveschakitvanich V, Soskolne V, van Griensven GJ. HIV-1 prevalence, HIV-1 subtypes and risk factors among fishermen in the Gulf of Thailand and the Andaman Sea. AIDS. 2000;14(8):1027-1034.
42. Romanowski B, Preiksaitis J, Campbell P, Fenton J. Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics. Sex Transm Dis. Jan 2003;30(1):33-38.
43. Segurado A, Braga P, Etzel A, Cardoso MR. Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDs. Mar 2004;18(3):135-143.
44. Zhou F, Ma Z, Hu W, et al. Study on the relationship between hepatitis C virus infection and sharing injection equipment, sexual behavior among injecting drug users. Zhonghua Liu Xing Bing Xue Za Zhi. Apr 2004;25(4):329-332.